Difference between revisions of "Part:BBa K1471005:Design"
(→References) |
|||
Line 16: | Line 16: | ||
===References=== | ===References=== | ||
− | + | Tiley LS1, Madore SJ, Malim MH, Cullen BR.(1992).The VP16 Transcription Activation Domain Is Functional When Targeted to a Promoter-proximal RNA Sequence. Genes Development. Volume 6; Issue 11; Pages: 2077-2087. | |
− | Carbone, A-L, M. Moroni, P-J Groot-Kormelink, and I. Bermudez. | + | Carbone, A-L, M. Moroni, P-J Groot-Kormelink, and I. Bermudez(2009).Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Britain Journal of Pharmacology.Volue 156; Issue 6; Pages 970–981. |
Revision as of 16:55, 1 November 2014
AGS (Linker) - VP16 (Activation domain).
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Source
References
Tiley LS1, Madore SJ, Malim MH, Cullen BR.(1992).The VP16 Transcription Activation Domain Is Functional When Targeted to a Promoter-proximal RNA Sequence. Genes Development. Volume 6; Issue 11; Pages: 2077-2087.
Carbone, A-L, M. Moroni, P-J Groot-Kormelink, and I. Bermudez(2009).Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Britain Journal of Pharmacology.Volue 156; Issue 6; Pages 970–981.